Ashima Singh1, Hartzell V Schaff2, Maria Mori Brooks1, Mark A Hlatky3, Stephen R Wisniewski1, Robert L Frye4, Edward Y Sako5. 1. Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA, USA. 2. Division of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, USA. 3. Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, USA. 4. Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA. 5. Department of Cardiothoracic Surgery, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA sako@uthscsa.edu.
Abstract
OBJECTIVES: Conclusive evidence is lacking regarding the benefits and risks of performing off-pump versus on-pump coronary artery bypass graft (CABG) for patients with diabetes. This study aims to compare clinical outcomes after off-pump and on-pump procedures for patients with diabetes. METHODS: The Bypass Angioplasty RevascularizationInvestigation 2 Diabetes (BARI 2D) trial enrolled patients with type 2 diabetes and documented coronary artery disease, 615 of whom underwent CABG during the trial. The procedural complications, 30-day outcomes, long-term clinical and functional outcomes were compared between the off-pump and on-pump groups overall and within a subset of patients matched on propensity score. RESULTS: On-pump CABG was performed in 444 (72%) patients, and off-pump CABG in 171 (28%). The unadjusted 30-day rate of death/myocardial infarction (MI)/stroke was significantly higher after off-pump CABG (7.0 vs 2.9%, P = 0.02) despite fewer complications (10.3 vs 20.7%, P = 0.003). The long-term risk of death [adjusted hazard ratio (aHR): 1.41, P = 0.2197] and major cardiovascular events (death, MI or stroke) (aHR: 1.47, P = 0.1061) did not differ statistically between the off-pump and on-pump patients. Within the propensity-matched sample (153 pairs), patients who underwent off-pump CABG had a higher risk of the composite outcome of death, MI or stroke (aHR: 1.83, P = 0.046); the rates of procedural complications and death did not differ significantly, and there were no significant differences in the functional outcomes. CONCLUSIONS:Patients with diabetes had greater risk of major cardiovascular events long-term after off-pump CABG than after on-pump CABG.
RCT Entities:
OBJECTIVES: Conclusive evidence is lacking regarding the benefits and risks of performing off-pump versus on-pump coronary artery bypass graft (CABG) for patients with diabetes. This study aims to compare clinical outcomes after off-pump and on-pump procedures for patients with diabetes. METHODS: The Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial enrolled patients with type 2 diabetes and documented coronary artery disease, 615 of whom underwent CABG during the trial. The procedural complications, 30-day outcomes, long-term clinical and functional outcomes were compared between the off-pump and on-pump groups overall and within a subset of patients matched on propensity score. RESULTS: On-pump CABG was performed in 444 (72%) patients, and off-pump CABG in 171 (28%). The unadjusted 30-day rate of death/myocardial infarction (MI)/stroke was significantly higher after off-pump CABG (7.0 vs 2.9%, P = 0.02) despite fewer complications (10.3 vs 20.7%, P = 0.003). The long-term risk of death [adjusted hazard ratio (aHR): 1.41, P = 0.2197] and major cardiovascular events (death, MI or stroke) (aHR: 1.47, P = 0.1061) did not differ statistically between the off-pump and on-pump patients. Within the propensity-matched sample (153 pairs), patients who underwent off-pump CABG had a higher risk of the composite outcome of death, MI or stroke (aHR: 1.83, P = 0.046); the rates of procedural complications and death did not differ significantly, and there were no significant differences in the functional outcomes. CONCLUSIONS:Patients with diabetes had greater risk of major cardiovascular events long-term after off-pump CABG than after on-pump CABG.
Authors: Brack Hattler; John C Messenger; A Laurie Shroyer; Joseph F Collins; Scott J Haugen; Joel A Garcia; Janet H Baltz; Joseph C Cleveland; Dimitri Novitzky; Frederick L Grover Journal: Circulation Date: 2012-05-16 Impact factor: 29.690
Authors: André Renner; Armin Zittermann; Anas Aboud; Thomas Pühler; Kavous Hakim-Meibodi; Wulf Quester; Diethelm Tschoepe; Jochen Börgermann; Jan F Gummert Journal: Ann Thorac Surg Date: 2013-06-21 Impact factor: 4.330
Authors: Edward L Hannan; Chuntao Wu; Craig R Smith; Robert S D Higgins; Russell E Carlson; Alfred T Culliford; Jeffrey P Gold; Robert H Jones Journal: Circulation Date: 2007-08-20 Impact factor: 29.690
Authors: Robert L Frye; Phyllis August; Maria Mori Brooks; Regina M Hardison; Sheryl F Kelsey; Joan M MacGregor; Trevor J Orchard; Bernard R Chaitman; Saul M Genuth; Suzanne H Goldberg; Mark A Hlatky; Teresa L Z Jones; Mark E Molitch; Richard W Nesto; Edward Y Sako; Burton E Sobel Journal: N Engl J Med Date: 2009-06-07 Impact factor: 91.245
Authors: Abduzhappar Gaipov; Miklos Z Molnar; Praveen K Potukuchi; Keiichi Sumida; Robert B Canada; Oguz Akbilgic; Kairat Kabulbayev; Zoltan Szabo; Santhosh K G Koshy; Kamyar Kalantar-Zadeh; Csaba P Kovesdy Journal: J Thorac Cardiovasc Surg Date: 2018-09-27 Impact factor: 5.209